Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice
- 31 January 2008
- journal article
- Published by Elsevier BV in Biomedicine & Pharmacotherapy
- Vol. 62 (1), 46-52
- https://doi.org/10.1016/j.biopha.2007.06.014
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 36 references indexed in Scilit:
- Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitusAmerican Heart Journal, 2006
- Peroxisome Proliferator–Activated Receptor-γ Activation With Pioglitazone Improves Endothelium-Dependent Dilation in Nondiabetic Patients With Major Cardiovascular Risk FactorsCirculation, 2006
- Delayed Arteriogenesis in Hypercholesterolemic MiceCirculation, 2005
- Peroxisome Proliferator-Activated Receptors and AtherogenesisCirculation Research, 2004
- Nitric Oxide Production and Regulation of Endothelial Nitric-oxide Synthase Phosphorylation by Prolonged Treatment with TroglitazonePublished by Elsevier BV ,2004
- Ginkgo bilobaExtract Inhibits Tumor Necrosis Factor-α–Induced Reactive Oxygen Species Generation, Transcription Factor Activation, and Cell Adhesion Molecule Expression in Human Aortic Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Endothelial nitric oxide synthase is essential for the HMG‐CoA reductase inhibitor cerivastatin to promote collateral growth in response to ischemiaThe FASEB Journal, 2001
- Therapeutic Angiogenesis for Ischemic Cardiovascular DiseaseJournal of Molecular and Cellular Cardiology, 2001
- Role of Nitric Oxide–cGMP Pathway in Adrenomedullin-Induced Vasodilation in the RatHypertension, 1999
- Nitric oxide synthase modulates angiogenesis in response to tissue ischemia.JCI Insight, 1998